TYMS POLYMORPHISMS AND METHOTREXATE THERAPEUTIC OUTCOME IN RHEUMATOID ARTHRITIS PORTUGUESE PATIENTS: ANALYSIS OF KEY POLYMORPHISMS

被引：0
|
作者：
Lima, A. [1 ,2 ,3 ]
Seabra, V. [1 ]
Bernardes, M. [4 ]
Azevedo, A. R. [5 ]
Sousa, H. [5 ]
Medeiros, R. [5 ]
机构：
[1] Gandra PRD, Inst Res & Adv Training Hlth Sci & Technol, Higher Inst Hlth Sci ISCS N, Dept Pharmaceut Sci,IINFACTS CESPU, Oporto, Portugal
[2] Univ Porto, Abel Salazar Inst Biomed Sci ICBAS, P-4100 Oporto, Portugal
[3] Portuguese Inst Oncol Porto IPO Porto, CI, Mol Oncol Grp, Oporto, Portugal
[4] Sao Joao Hosp Ctr, Rheumatol Dept, Oporto, Portugal
[5] Portuguese Inst Oncol Porto IPO Porto, Mol Oncol Grp CI, Oporto, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.4672
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0457
引用
收藏
页码：341 / 341
页数：1
相关论文
共 50 条
  • [1] Role of Key TYMS Polymorphisms on Methotrexate Therapeutic Outcome in Portuguese Rheumatoid Arthritis Patients
    Lima, Aurea
    Seabra, Vitor
    Bernardes, Miguel
    Azevedo, Rita
    Sousa, Hugo
    Medeiros, Rui
    PLOS ONE, 2014, 9 (10):
  • [2] TYMS polymorphisms and responsiveness to or toxicity of methotrexate in rheumatoid arthritis
    Bae, Sang-Cheol
    Lee, Young Ho
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2018, 77 (09): : 824 - 832
  • [3] ASSOCIATIONS BETWEEN TYMS POLYMORPHISMS AND RESPONSIVENESS TO OR TOXICITY OF METHOTREXATE IN RHEUMATOID ARTHRITIS
    Lee, Y. H.
    Seo, Y. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 567 - 567
  • [4] Effect of thymidylate synthase (TYMS) gene polymorphisms with methotrexate treatment outcome in south Indian Tamil patients with rheumatoid arthritis
    Niveditha Muralidharan
    Durga P. Misra
    Vikramraj K. Jain
    Vir Singh Negi
    Clinical Rheumatology, 2017, 36 : 1253 - 1259
  • [5] Effect of thymidylate synthase (TYMS) gene polymorphisms with methotrexate treatment outcome in south Indian Tamil patients with rheumatoid arthritis
    Muralidharan, Niveditha
    Misra, Durga P.
    Jain, Vikramraj K.
    Negi, Vir Singh
    CLINICAL RHEUMATOLOGY, 2017, 36 (06) : 1253 - 1259
  • [6] MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms
    Owen, S. A.
    Lunt, M.
    Bowes, J.
    Hider, S. L.
    Bruce, I. N.
    Thomson, W.
    Barton, A.
    PHARMACOGENOMICS JOURNAL, 2013, 13 (02): : 137 - 147
  • [7] MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms
    S A Owen
    M Lunt
    J Bowes
    S L Hider
    I N Bruce
    W Thomson
    A Barton
    The Pharmacogenomics Journal, 2013, 13 : 137 - 147
  • [8] Genetic Polymorphisms of TYMS, MTHFR, ATIC, MTR, and MTRR Are Related to the Outcome of Methotrexate Therapy for Rheumatoid Arthritis in a Chinese Population
    Lv, Shuang
    Fan, HuiZhen
    Li, Jiang
    Yang, Hui
    Huang, Jing
    Shu, XiaoMing
    Zhang, Lu
    Xu, Yuan
    Li, Xiaoya
    Zuo, Jieyu
    Xiao, Cheng
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [9] Genetic polymorphisms and Methotrexate response in patients with rheumatoid arthritis
    Grk, Milka
    Jekic, Biljana
    Dolzan, Vita
    Maksimovic, Nela
    Damnjanovic, Tatjana
    Rasic, Milica
    Novakovic, Ivana
    Perovic, Dijana
    Carkic, Jelena
    Dusanovic Pjevic, Marija
    JOURNAL OF RESEARCH IN PHARMACY, 2024, 28 (04): : 1285 - 1292
  • [10] Polymorphisms in genes involved in the mechanism of action of methotrexate: are they associated with outcome in rheumatoid arthritis patients?
    Salazar, Juliana
    Moya, Patricia
    Altes, Albert
    Diaz-Torne, Cesar
    Casademont, Jordi
    Cerda-Gabaroi, Dacia
    Corominas, Hector
    Baiget, Montserrat
    PHARMACOGENOMICS, 2014, 15 (08) : 1079 - 1090
12345